Literature DB >> 10419519

26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate.

S Ben-Shahar1, A Komlosh, E Nadav, I Shaked, T Ziv, A Admon, G N DeMartino, Y Reiss.   

Abstract

Peptides displayed on the cell surface by major histocompatibility class I molecules (MHC class I) are generated by proteolytic processing of protein-antigens in the cytoplasm. Initially, antigens are degraded by the 26 S proteasome, most probably following ubiquitination. However, it is unclear whether this proteolysis results in the generation of MHC class I ligands or if further processing is required. To investigate the role of the 26 S proteasome in antigen presentation, we analyzed the processing of an intact antigen by purified 26 S proteasome. A recombinant ornithine decarboxylase was produced harboring the H-2K(b)-restricted peptide epitope, derived from ovalbumin SIINFEKL (termed ODC-ova). Utilizing recombinant antizyme to target the antigen to the 26 S proteasome, we found that proteolysis of ODC-ova by the 26 S proteasome resulted in the generation of the K(b)-ligand. Mass spectrometry analysis indicated that in addition to SIINFEKL, the N-terminally extended ligand, HSIINFEKL, was also generated. Production of SIINFEKL was linear with time and directly proportional to the rate of ODC-ova degradation. The overall yield of SIINFEKL was approximately 5% of the amount of ODC-ova degraded. The addition of PA28, the 20 S, or the 20 S-PA28 complex to the 26 S proteasome did not significantly affect the yield of the antigenic peptide. These findings demonstrate that the 26 S proteasome can efficiently digest an intact physiological substrate and generate an authentic MHC class I-restricted epitope.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419519     DOI: 10.1074/jbc.274.31.21963

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.

Authors:  Avital Lev; Michael F Princiotta; Damian Zanker; Kazuyo Takeda; James S Gibbs; Chiharu Kumagai; Elizabeth Waffarn; Brian P Dolan; Anne Burgevin; Peter Van Endert; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.

Authors:  S Murata; H Udono; N Tanahashi; N Hamada; K Watanabe; K Adachi; T Yamano; K Yui; N Kobayashi; M Kasahara; K Tanaka; T Chiba
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

4.  Association of growth factors, HIF-1 and NF-κB expression with proteasomes in endometrial cancer.

Authors:  Ludmila V Spirina; Nataliya V Yunusova; Irina V Kondakova; Larisa A Kolomiets; Valeriya D Koval; Alena L Chernyshova; Olga V Shpileva
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

5.  Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Authors:  W M Cohen; A Bianco; F Connan; L Camoin; M Dalod; G Lauvau; E Ferriès; B Culmann-Penciolelli; P M van Endert; J P Briand; J Choppin; J G Guillet
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities.

Authors:  Liudmila V Spirina; Irina V Kondakova; Evgeny L Choynzonov; Svetlana Y Chigevskaya; Dmitry A Shishkin; Denis Y Kulbakin
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-27       Impact factor: 4.553

7.  Changes in the Proteasome Pool during Malignant Transformation of Mouse Liver Cells.

Authors:  T M Astakhova; G V Delone; Yu V Lyupina; E B Abramova; I V Uryvaeva; N P Sharova
Journal:  Acta Naturae       Date:  2010-04       Impact factor: 1.845

8.  Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.

Authors:  A J Sijts; T Ruppert; B Rehermann; M Schmidt; U Koszinowski; P M Kloetzel
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

9.  Proteasome functioning in breast cancer: connection with clinical-pathological factors.

Authors:  Elena E Shashova; Yulia V Lyupina; Svetlana A Glushchenko; Elena M Slonimskaya; Olga V Savenkova; Alexey M Kulikov; Nikolay G Gornostaev; Irina V Kondakova; Natalia P Sharova
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

10.  Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome.

Authors:  Natalia Yunusova; Elena Kolegova; Elena Sereda; Larisa Kolomiets; Alisa Villert; Marina Patysheva; Irina Rekeda; Alina Grigor'eva; Natalia Tarabanovskaya; Irina Kondakova; Svetlana Tamkovich
Journal:  Molecules       Date:  2021-11-18       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.